Apresoline Ampoules 20 mg Powder for concentrate for solution for injection or infusion
- Licence status
- Withdrawn: 15/12/2019
- Active substances
- HYDRALAZINE HYDROCHLORIDE
- Dosage Form
- Powder for concentrate for solution for injection/infusion
- Licence number
- PA1142/015/001
- Licence holder
- Amdipharm Limited
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- C02DB Hydrazinophthalazine derivatives, C02DB02 hydralazine
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- The reconstituted powder must be diluted before use.
- Marketing availability
- Not marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 01/04/1979